# Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

> **NCT05070754** · PHASE4 · COMPLETED · sponsor: **Medical University of South Carolina** · enrollment: 17 (actual)

## Conditions studied

- Verruca Vulgaris
- Molluscum Contagiosum Skin Infection

## Interventions

- **DEVICE:** Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
- **DEVICE:** Cryotherapy
- **DRUG:** Canthardin Collodion

## Key facts

- **NCT ID:** NCT05070754
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-02
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2024-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05070754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05070754, "Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05070754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*